Cargando…
Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one
Peptide(540–548), peptide(611–626), peptide(672–686) and peptide(766–780), which are derived from human telomerase, constitute the immunogenic component of the GX301 cancer vaccine. The relative immunogenicity of these peptides is unknown, thus it is unsure whether their combined use offers real adv...
Autores principales: | Fenoglio, Daniela, Parodi, Alessia, Lavieri, Rosa, Kalli, Francesca, Ferrera, Francesca, Tagliamacco, Augusto, Guastalla, Andrea, Lamperti, Maria Giuseppina, Giacomini, Mauro, Filaci, Gilberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514186/ https://www.ncbi.nlm.nih.gov/pubmed/25714118 http://dx.doi.org/10.1080/21645515.2015.1012032 |
Ejemplares similares
-
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial
por: Filaci, Gilberto, et al.
Publicado: (2021) -
Phenotypic Alterations Involved in CD8+ Treg Impairment in Systemic Sclerosis
por: Negrini, Simone, et al.
Publicado: (2017) -
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in mice
por: Kalli, Francesca, et al.
Publicado: (2013) -
Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence
por: Parodi, Alessia, et al.
Publicado: (2016) -
AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanoma
por: Conteduca, Giuseppina, et al.
Publicado: (2016)